These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 648093)

  • 1. Clinical dosimetry of the rectum in cathetron applications for treatment of carcinoma of the uterine cavity.
    Santhamma AV; Das KR
    Clin Radiol; 1978 May; 29(3):343-5. PubMed ID: 648093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry of intracavitary applications in carcinoma of the cervix: rectal dose analysis.
    Deshpande DD; Shrivastav SK; Pradhan AS; Viswanathan PS; Dinshaw KA
    Radiother Oncol; 1997 Feb; 42(2):163-6. PubMed ID: 9106925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis.
    Clark BG; Souhami L; Roman TN; Evans MD; Pla C
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1243-50. PubMed ID: 8175412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of dose and time-dose-fractionation factors (TDF) with treatment results and side effects in cancer of the uterine cervix.
    Yudelev M; Kuten A; Tatcher M; Rubinov R; Karmeli R; Cohen Y; Robinson E
    Gynecol Oncol; 1986 Mar; 23(3):310-5. PubMed ID: 3957116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients.
    Huh SJ; Lim DH; Ahn YC; Lee JE; Kang MK; Shin SS; Shin KH; Kim B; Park W; Han Y
    Strahlenther Onkol; 2003 Mar; 179(3):191-6. PubMed ID: 12627263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder and rectal complications following radiotherapy for cervix cancer.
    Stryker JA; Bartholomew M; Velkley DE; Cunningham DE; Mortel R; Craycraft G; Shafer J
    Gynecol Oncol; 1988 Jan; 29(1):1-11. PubMed ID: 3338655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications.
    Montana GS; Fowler WC
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):95-100. PubMed ID: 2912959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer of the uterine cervix: dosimetric guidelines for prevention of late rectal and rectosigmoid complications as a result of radiotherapeutic treatment.
    Pourquier H; Dubois JB; Delard R
    Int J Radiat Oncol Biol Phys; 1982 Nov; 8(11):1887-95. PubMed ID: 6818192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma.
    Sha RL; Reddy PY; Rao R; Muralidhar KR; Kudchadker RJ
    Med Dosim; 2011; 36(4):377-82. PubMed ID: 21144733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
    Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
    Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal complications in patients with carcinoma of the cervix: the concept of a rectal reference dose.
    Grigsby PW
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1271-2. PubMed ID: 8175416
    [No Abstract]   [Full Text] [Related]  

  • 16. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix.
    Clark BG; Souhami L; Roman TN; Chappell R; Evans MD; Fowler JF
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):989-93. PubMed ID: 9276363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
    Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
    Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Kim KH; Kim S; Kim GE; Koom WS; Kim SW; Nam EJ; Suh CO; Kim YB
    Gynecol Oncol; 2015 Dec; 139(3):439-46. PubMed ID: 26456139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications.
    Sakata K; Nagakura H; Oouchi A; Someya M; Nakata K; Shido M; Koito K; Sagae S; Kudo R; Hareyama M
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1369-76. PubMed ID: 12459359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.